# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-014545
Filing Date
2021-04-27
Accepted
2021-04-27 16:17:34
Documents
24
Period of Report
2021-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | nc10021408x1_def14a.htm | DEF 14A | 2311506
2 |  | amicus_leaf.jpg | GRAPHIC | 8964
3 |  | logo_amicus.jpg | GRAPHIC | 82920
4 |  | nc10021408x1_bleil.jpg | GRAPHIC | 50188
5 |  | nc10021408x1_campbell.jpg | GRAPHIC | 40985
6 |  | nc10021408x1_crowley.jpg | GRAPHIC | 45401
7 |  | nc10021408x1_diverity.jpg | GRAPHIC | 210076
8 |  | nc10021408x1_esg.jpg | GRAPHIC | 314998
9 |  | nc10021408x1_essner.jpg | GRAPHIC | 44589
10 |  | nc10021408x1_exp.jpg | GRAPHIC | 326735
11 |  | nc10021408x1_how2.jpg | GRAPHIC | 333834
12 |  | nc10021408x1_kelly.jpg | GRAPHIC | 34202
13 |  | nc10021408x1_mcglynn.jpg | GRAPHIC | 48621
14 |  | nc10021408x1_pc1.jpg | GRAPHIC | 583248
15 |  | nc10021408x1_pc2.jpg | GRAPHIC | 419449
16 |  | nc10021408x1_piechart.jpg | GRAPHIC | 274456
17 |  | nc10021408x1_qr.jpg | GRAPHIC | 27364
18 |  | nc10021408x1_raab.jpg | GRAPHIC | 46611
19 |  | nc10021408x1_sblendorio.jpg | GRAPHIC | 42947
20 |  | nc10021408x1_score.jpg | GRAPHIC | 374915
21 |  | nc10021408x1_wheeler.jpg | GRAPHIC | 44925
22 |  | nc10021408x1_whiteman.jpg | GRAPHIC | 41993
23 |  | nc10021408x999_sig1.jpg | GRAPHIC | 22411
24 |  | nc10021408x999_sig2.jpg | GRAPHIC | 23726
| Complete submission text file | 0001140361-21-014545.txt |  | 7051080

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33497 | Film No.: 21859144
SIC: 2834 Pharmaceutical Preparations